The late-stage clinical trial results showed that Eli Lilly’s once-weekly insulin efsitora matched daily injections for patients with type 1 and 2 diabetes, respectively.
Tag Archive for: efsitora
Eli Lilly’s weekly insulin injection efsitora alfa secured two late-stage victories on Thursday in a blow to rival Novo Nordisk, which in July failed to secure the FDA’s approval for its basal insulin icodec.
Eli Lilly said its once-weekly insulin injection, efsitora, showed blood sugar reduction that was consistent with commonly used daily insulins across two studies in patients with type 2 diabetes.